Comparison 1. Statin versus placebo / no treatment.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 All‐cause mortality	3	178	Risk Ratio (M‐H, Random, 95% CI)	0.73 [0.31, 1.75]
2 Death from cardiovascular causes	3	178	Risk Ratio (M‐H, Random, 95% CI)	1.05 [0.07, 16.20]
3 Myocardial infarction (non‐fatal)	3	178	Risk Ratio (M‐H, Random, 95% CI)	0.47 [0.15, 1.52]
4 Stroke or TIA (non‐fatal)	3	178	Risk Ratio (M‐H, Random, 95% CI)	0.24 [0.03, 2.25]
5 New atrial fibrillation	2	88	Risk Ratio (M‐H, Random, 95% CI)	1.73 [0.20, 14.84]
6 Length of stay			Other data	No numeric data
7 Graft patency	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
7.1 Restenosis required	1	37	Risk Ratio (M‐H, Random, 95% CI)	0.53 [0.19, 1.45]
7.2 Amputation required	2	49	Risk Ratio (M‐H, Random, 95% CI)	0.63 [0.16, 2.53]
8 Clinical muscle syndromes	3		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only